Your search returned 39 studies:
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Springfield, Massachusetts
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Springfield, Massachusetts
- Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Conditions: Recurrent Prostate Cancer - Stage I Prostate Cancer - Stage IIA Prostate Cancer - Stage IIB Prostate Cancer - Stage III Prostate Cancer
Location: Springfield, Massachusetts
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: New Britain, Connecticut
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma - Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Hartford, Connecticut
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
Conditions: Prostate Cancer
Location: Hartford, Connecticut
- Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer
Conditions: Prostate Cancer
Location: New Britain, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Norwich, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: West Haven, Connecticut
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Middletown, Connecticut
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Norwich, Connecticut
- Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer
Conditions: Impotence - Prostatic Neoplasms
Location: Hartford, Connecticut
- A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Andr
Conditions: Cancer - Cataract - Low Bone Mineral Density - Osteopenia - Osteoporosis - Prostate Cancer
Location: New Britain, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Farmington, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Hartford, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Hartford, Connecticut
- Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
Conditions: Prostate Cancer
Location: Middletown, Connecticut
- Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Conditions: Recurrent Prostate Cancer - Stage I Prostate Cancer - Stage IIA Prostate Cancer - Stage IIB Prostate Cancer - Stage III Prostate Cancer
Location: Hartford, Connecticut
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Farmington, Connecticut
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: New Britain, Connecticut
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: New Haven, Connecticut
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: New Haven, Connecticut
- A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Andr
Conditions: Cancer - Cataract - Low Bone Mineral Density - Osteopenia - Osteoporosis - Prostate Cancer
Location: Middlebury, Connecticut
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Bridgeport, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Norwich, Connecticut
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: New Haven, Connecticut
- A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Conditions: Prostatic Neoplasms
Location: Middlebury, Connecticut
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: New Haven, Connecticut
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Norwich, Connecticut
- Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Bridgeport, Connecticut
- Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abir
Conditions: Prostate Cancer - Castration Resistant Prostate Cancer - Pain - Prostatic Neoplasms
Location: Southington, Connecticut
- Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abir
Conditions: Prostate Cancer - Castration Resistant Prostate Cancer - Pain - Prostatic Neoplasms
Location: New Haven, Connecticut
- Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
Conditions: Prostate Cancer
Location: Middlebury, Connecticut
- A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
Conditions: Prostate Cancer
Location: New Haven, Connecticut
|